Design, synthesis and characterization of "clickable'' 4-anilinoquinazoline kinase inhibitors

被引:9
作者
Gayani, B. [1 ]
Perera, K. [1 ]
Maly, Dustin J. [1 ]
机构
[1] Univ Washington, Dept Chem, Seattle, WA 98195 USA
关键词
D O I
10.1039/b720014e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immobilized kinase inhibitors have emerged as powerful reagents for the determination of kinase inhibitor selectivity and for the enrichment of protein targets from cellular lysates. Here, we report the design and synthesis of a set of "clickable'' 4-anilinoquinazoline kinase inhibitors. We demonstrate that the attachment of a flexible tether that contains a bio-orthogonal azide functionality does not adversely affect the potency or selectivity of these inhibitors. Furthermore, we demonstrate the utility of these inhibitors through the generation of an affinity matrix for the enrichment of interacting proteins from cellular lysates.
引用
收藏
页码:542 / 550
页数:9
相关论文
共 61 条
[1]   A strategy for the design of multiplex inhibitors for kinase-mediated signalling in angiogenesis [J].
Adams, J ;
Huang, P ;
Patrick, D .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2002, 6 (04) :486-492
[2]  
[Anonymous], [No title captured], Patent No. 2001094341
[3]   Roscovitine targets, protein kinases and pyridoxal kinase [J].
Bach, S ;
Knockaert, M ;
Reinhardt, J ;
Lozach, O ;
Schmitt, S ;
Baratte, B ;
Koken, M ;
Coburn, SP ;
Tang, L ;
Jiang, T ;
Liang, DC ;
Galons, H ;
Dierick, JF ;
Pinna, LA ;
Meggio, F ;
Totzke, F ;
Schächtele, C ;
Lerman, AS ;
Carnero, A ;
Wan, YQ ;
Gray, N ;
Meijer, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (35) :31208-31219
[4]   The specificities of protein kinase inhibitors: an update [J].
Bain, J ;
McLauchlan, H ;
Elliott, M ;
Cohen, P .
BIOCHEMICAL JOURNAL, 2003, 371 :199-204
[5]   Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors [J].
Bantscheff, Marcus ;
Eberhard, Dirk ;
Abraham, Yann ;
Bastuck, Sonja ;
Boesche, Markus ;
Hobson, Scott ;
Mathieson, Toby ;
Perrin, Jessica ;
Raida, Manfred ;
Rau, Christina ;
Reader, Valerie ;
Sweetman, Gavain ;
Bauer, Andreas ;
Bouwmeester, Tewis ;
Hopf, Carsten ;
Kruse, Ulrich ;
Neubauer, Gitte ;
Ramsden, Nigel ;
Rick, Jens ;
Kuster, Bernhard ;
Drewes, Gerard .
NATURE BIOTECHNOLOGY, 2007, 25 (09) :1035-1044
[6]   A three-hybrid approach to scanning the proteome for targets of small molecule kinase inhibitors [J].
Becker, F ;
Murthi, K ;
Smith, C ;
Come, J ;
Costa-Roldán, N ;
Kaufmann, C ;
Hanke, U ;
Degenhart, C ;
Baumann, S ;
Wallner, W ;
Huber, A ;
Dedier, S ;
Dill, S ;
Kinsman, D ;
Hediger, M ;
Bockovich, N ;
Meier-Ewert, S ;
Kluge, AF ;
Kley', N .
CHEMISTRY & BIOLOGY, 2004, 11 (02) :211-223
[7]  
Brehmer D, 2005, CANCER RES, V65, P379
[8]  
Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139
[9]   A proteome-wide CDK/CRK-specific kinase inhibitor promotes tumor cell death in the absence of cell cycle progression [J].
Caligluri, M ;
Becker, F ;
Murthi, K ;
Kaplan, F ;
Dedier, S ;
Kaufmann, C ;
Machl, A ;
Zybarth, G ;
Richard, J ;
Bockovich, N ;
Kluge, A ;
Kley, N .
CHEMISTRY & BIOLOGY, 2005, 12 (10) :1103-1115
[10]   Protein kinases - the major drug targets of the twenty-first century? [J].
Cohen, P .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (04) :309-315